S. Rachel Skinner
S. Rachel Skinner
Professor, Discipline of Child and Adolescent Health, University of Sydney, Faculty of Medicine and
Verified email at health.nsw.gov.au
Title
Cited by
Cited by
Year
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a …
J Paavonen, P Naud, J Salmerón, CM Wheeler, SN Chow, D Apter, ...
The Lancet 374 (9686), 301-314, 2009
17832009
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of …
J Paavonen, D Jenkins, FX Bosch, P Naud, J Salmerón, CM Wheeler, ...
The Lancet 369 (9580), 2161-2170, 2007
15002007
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double …
M Lehtinen, J Paavonen, CM Wheeler, U Jaisamrarn, SM Garland, ...
The lancet oncology 13 (1), 89-99, 2012
7342012
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis …
CM Wheeler, X Castellsagué, SM Garland, A Szarewski, J Paavonen, ...
The lancet oncology 13 (1), 100-110, 2012
5092012
Young adult sequelae of adolescent cannabis use: an integrative analysis
E Silins, LJ Horwood, GC Patton, DM Fergusson, CA Olsson, ...
The Lancet Psychiatry 1 (4), 286-293, 2014
4002014
Fall in human papillomavirus prevalence following a national vaccination program
SN Tabrizi, JML Brotherton, JM Kaldor, SR Skinner, E Cummins, B Liu, ...
The Journal of infectious diseases 206 (11), 1645-1651, 2012
3032012
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
SN Tabrizi, JML Brotherton, JM Kaldor, SR Skinner, B Liu, D Bateson, ...
The Lancet infectious diseases 14 (10), 958-966, 2014
2532014
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
AR Kreimer, F Struyf, MR Del Rosario-Raymundo, A Hildesheim, ...
The lancet oncology 16 (7), 775-786, 2015
2442015
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double …
SR Skinner, A Szarewski, B Romanowski, SM Garland, E Lazcano-Ponce, ...
The Lancet 384 (9961), 2213-2227, 2014
1662014
Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18
A Szarewski, WAJ Poppe, SR Skinner, CM Wheeler, J Paavonen, P Naud, ...
International Journal of Cancer 131 (1), 106-116, 2012
1382012
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study
U Jaisamrarn, X Castellsague, SM Garland, P Naud, J Palmroth, ...
PloS one 8 (11), e79260, 2013
1332013
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind …
CM Wheeler, SR Skinner, MR Del Rosario-Raymundo, SM Garland, ...
The Lancet Infectious Diseases 16 (10), 1154-1168, 2016
1132016
Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy
LN Lewis, DA Doherty, M Hickey, SR Skinner
Contraception 81 (5), 421-426, 2010
1062010
Adolescent and young adult HPV vaccination in Australia: achievements and challenges
SM Garland, SR Skinner, JML Brotherton
Preventive medicine 53, S29-S35, 2011
1042011
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial
ER Bahmanyar, J Paavonen, P Naud, J Salmerón, SN Chow, D Apter, ...
Gynecologic oncology 127 (3), 440-450, 2012
992012
“Is cancer contagious?”: Australian adolescent girls and their parents: Making the most of limited information about HPV and HPV vaccination
SCC Robbins, D Bernard, K McCaffery, J Brotherton, S Garland, ...
Vaccine 28 (19), 3398-3408, 2010
992010
Very low prevalence of vaccine human papillomavirus types among 18-to 35-year old Australian women 9 years following implementation of vaccination
DA Machalek, SM Garland, JML Brotherton, D Bateson, K McNamee, ...
The Journal of infectious diseases 217 (10), 1590-1600, 2018
952018
Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the …
D Apter, CM Wheeler, J Paavonen, X Castellsagué, SM Garland, ...
Clinical and Vaccine Immunology 22 (4), 361-373, 2015
872015
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation
A Szarewski, SR Skinner, SM Garland, B Romanowski, TF Schwarz, ...
The Journal of infectious diseases 208 (9), 1391-1396, 2013
832013
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
S Rachel Skinner, CM Wheeler, B Romanowski, X Castellsagué, ...
International journal of cancer 138 (10), 2428-2438, 2016
812016
The system can't perform the operation now. Try again later.
Articles 1–20